Toxoplasmosis.
D000818:Animals; D000906:Antibodies; D002415:Cats; D019411:Clinical Laboratory Techniques; D004199:Disease Vectors; D006801:Humans; D007109:Immunity; D007933:Leucomycins / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014122:Toxoplasma / Q000472:pathogenicity; D014123:Toxoplasmosis / Q000188:drug therapy; D014125:Toxoplasmosis, Congenital; D014126:Toxoplasmosis, Ocular
D000906:Antibodies; D007933:Leucomycins; D013449:Sulfonamides; D011739:Pyrimethamine